Xelari's AI-powered platform transforms how molecular binders are designed, addressing critical limitations in biotechnology.
Our XELAMERs (DNA/RNA-based functional molecular binders) surpass antibodies and aptamers in all key performance metrics, revolutionizing molecular binding technology.
The Problem
While 80% of biotech companies rely on antibodies for R&D:
- Antibody discovery takes over a year and costs hundreds of thousands
- Production requires months with cold-chain logistics
- Aptamers have only 30% success rate
Our Solution: XELAMERs
- 24-hour design time versus 6-12 months for antibodies
- Thousands of times more cost-efficient
- Multi-functional: Each XELAMER can perform up to 5 distinct functions
Contact: info@xelari.com | www.xelari.com
Company Details
- Employees
- 6
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://xelari.com
- Keywords
- IT Consulting.
Xelari Inc. Questions
Xelari Inc.'s website is https://xelari.com
Xelari Inc.'s LinkedIn profile is https://www.linkedin.com/company/xelari
Xelari Inc. has
6 employees.
View email and phone details for 6
employees at Xelari Inc..
Xelari Inc.'s industry is
Biotechnology Research
Xelari Inc.'s top competitors are
Aptamer Sciences Inc.,
Allset,
Materia Collection,
Lora Health,
Bitfury,
Uc International College (Ucic),
Children Against Abortion, Pornography, And Molestation,
Italdoors Llc,
I-Box Create S.l.,
Optic.
Xelari Inc.'s categories are Biotechnology Research
Xelari Inc.'s founding year is 2018
